Longitudinal characterization of [18F]-FDG and [18F]-AV45 uptake in the double transgenic TASTPM mouse model
Manuscript Number:
16-0760R1
Author(s):
Xavier Langlois, Jill Richardson, Mark Schmidt, Steven Staelens, Sigrid Stroobants, Jeroen Verhaeghe, Ann-Marie Waldron, Leonie wyffels
Disclosures
Xavier Langlois
Equity:
I own JNJ stocks
Sponsors:
Scientific director
Jill Richardson
Equity:
I am a full time employed of GlaxoSmithKline. GSK did not sponsor the study directly.
Mark Schmidt
Equity:
Equity in Johnson & Johnson in the form of share, and stock options
Stocks in a variety of other companies as investments, but JNJ is the most relevant to this mss as the sponsor of the study.
Sponsors:
Full time employment as a Senior Director in Janssen R&D, working as a senior clinical scientist in Neuroscience/Experimental Medicine